Frequent coauthors
- OHSHIMA ETSUO 108
- WATANABE AKIHIKO 108
- KIMOTO NAOYA 90
- MIYAKE KIYOMI 18
- WATANABE AKIKO 18
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.